Trial intelligence / Profile preview

Hexakapron for Bleeding Reduction in Bariatric Surgery

NCT03085394Phase 3Terminated

Sponsor
Sheba Medical Center
Start
Sep 2017
Primary completion
Nov 2022
Countries
1
01

Overview

A Phase 3 trial of tranexamic acid in postoperative hemorrhage, sponsored by Sheba Medical Center. Started Sep 2017; status: terminated.

02

Drugs

tranexamic acid
03

Conditions

postoperative hemorrhage

Beyond the preview

Go deeper on NCT03085394.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03085394.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call